Bank of Nova Scotia’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-268,760
Closed -$4M 1014
2023
Q4
$4M Buy
+268,760
New +$3.04M 0.01% 542
2023
Q1
Sell
-792,913
Closed -$9.69M 1161
2022
Q4
$9.69M Sell
792,913
-694,310
-47% -$8.65M 0.03% 356
2022
Q3
$18.5M Sell
1,487,223
-271,911
-15% -$4.75M 0.06% 233
2022
Q2
$34.5M Buy
1,759,134
+3,670
+0.2% +$86.9K 0.08% 201
2022
Q1
$45.8M Sell
1,755,464
-499,692
-22% -$13.3M 0.08% 209
2021
Q4
$64M Buy
2,255,156
+1,973,044
+699% +$61.4M 0.09% 206
2021
Q3
$9M Buy
282,112
+2,112
+0.8% +$70.9K 0.02% 498
2021
Q2
$9.71M Buy
+280,000
New +$9.23M 0.02% 451
2020
Q1
Sell
-121,248
Closed -$3.57M 918
2019
Q4
$3.57M Sell
121,248
-132,945
-52% -$3.61M 0.01% 582
2019
Q3
$6.76M Buy
+254,193
New +$7.63M 0.02% 444

Other funds holding ELAN

Bank of Nova Scotia's ELAN Position: Q1 2024 in Review

Bank of Nova Scotia sold out of Elanco Animal Health (ELAN) in Q1 2024, closing a stake of 268,760 shares — an estimated $4M sold.

Bank of Nova Scotia first reported a position in ELAN in Q3 2019 and held it in 10 quarters. The position peaked at $64M in Q4 2021. 376 funds tracked by Wall St. Rank hold ELAN as of Q1 2024.

  • Bank of Nova Scotia reported no remaining Elanco Animal Health position as of Q1 2024 after selling out during the quarter.
  • Bank of Nova Scotia sold 268,760 Elanco Animal Health shares in Q1 2024, an estimated $4M.
  • Bank of Nova Scotia first reported a position in Elanco Animal Health in Q3 2019 and held it in 10 quarters.
  • Bank of Nova Scotia's Elanco Animal Health position peaked at $64M in Q4 2021.
  • 376 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2024.

Based on Bank of Nova Scotia's 13F filing for Q1 2024, filed 15 May 2024.